PalinGen® Membrane
Indications & Use
PalinGen® Membrane is a chorion-free amniotic membrane allograft intended for use as a protective wound covering to support the management of chronic, non-healing wounds in appropriate patients.
Clinical overview
This page provides high-level, clinician-facing guidance on common use cases, patient selection considerations, and practical application notes for PalinGen® Membrane. Always follow the product’s Instructions for Use (IFU) and facility protocols.
Indications
Common wound types where a protective covering may be used
PalinGen® Membrane may be used as a wound covering in the management of chronic wounds when clinically appropriate and after standard-of-care has been initiated.
Diabetic foot ulcers (DFUs)
For non-healing DFUs where offloading, debridement, infection control, and moisture balance are addressed and additional biologic support is desired.
Venous leg ulcers (VLUs)
For VLUs managed with compression therapy and appropriate local wound care, particularly when progress has stalled.
Pressure ulcers (PrUs)
For pressure injuries where pressure redistribution, nutrition optimization, and local wound care are in place.
Other chronic or complex wounds
May be considered for select surgical wounds, traumatic wounds, or other non-healing wounds based on clinician judgment and payer policy.
Patient selection
When to consider an amniotic membrane allograft
Use considerations
Application notes (summary)
Use as part of a comprehensive wound care plan. Clinicians typically prepare the wound bed, apply the allograft as a protective covering, and secure it with an appropriate non-adherent dressing and secondary dressings per protocol.
Frequency of re-application and total number of applications vary by wound characteristics, clinical response, and payer policy. Document wound measurements, standard-of-care elements, and medical necessity to support continuity of care and reimbursement.
